MARKET

ENOV

ENOV

Enovis Corp
NYSE
55.47
-0.04
-0.07%
After Hours: 55.47 0 0.00% 16:01 04/23 EDT
OPEN
55.24
PREV CLOSE
55.51
HIGH
56.17
LOW
55.24
VOLUME
454.16K
TURNOVER
0
52 WEEK HIGH
66.14
52 WEEK LOW
43.04
MARKET CAP
3.04B
P/E (TTM)
-90.8748
1D
5D
1M
3M
1Y
5Y
Benjamin Graham Detailed Fundamental Analysis - ENOV
NASDAQ · 1d ago
Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks
Enovis Corporation has a price-to-sales ratio of 1.8x compared to the Medical Equipment industry in the US. The company's revenue growth of late has been similar to most other companies. However, the company's P/S ratio is lower than the average for the industry. Despite strong future growth forecasts, Enovis' revenue growth is below industry average.
Simply Wall St · 1d ago
Weekly Report: what happened at ENOV last week (0415-0419)?
Weekly Report · 1d ago
Enovis Becomes Oversold (ENOV)
NASDAQ · 4d ago
Banzai Welcomes Over 580 New Customers In Q1, A Quarterly Increase Of 46%
Banzai added over 580 customers in Q1 2024. Of this, 400 were net new customers and 180 were reactivating customers. Banzai's new customer acquisition represents a quarterly increase of 46% compared to Q4 2023. Customers include Cisco, a Fortune 500 networking and security technology company.
Benzinga · 04/16 12:04
Notable Monday Option Activity: ENOV, JELD, MPW
NASDAQ · 04/15 19:18
Weekly Report: what happened at ENOV last week (0408-0412)?
Weekly Report · 04/15 09:05
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
More
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Webull offers Enovis Corp stock information, including NYSE: ENOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENOV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENOV stock methods without spending real money on the virtual paper trading platform.